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Objectives: To identify the genes responsible for tetracycline resistance in a strain of Streptococcus australis iso-
lated from pooled saliva from healthy volunteers in France. S. australis is a viridans Streptococcus, originally iso-
lated from the oral cavity of children in Australia, and subsequently reported in the lungs of cystic fibrosis
patients and as a cause of invasive disease in an elderly patient.
Methods: Agar containing 2 mg/L tetracycline was used for the isolation of tetracycline-resistant organisms.
A genomic library in Escherichia coli was used to isolate the tetracycline resistance determinant. In-frame dele-
tions and chromosomal repair were used to confirm function. Antibiotic susceptibility was determined by agar
dilution and disc diffusion assay.
Results: The tetracycline resistance determinant from S. australis FRStet12 was isolated from a genomic library
in E. coli and DNA sequencing showed two open reading frames predicted to encode proteins with similarity to
multidrug resistance-type ABC transporters. Both genes were required for tetracycline resistance (to both the
naturally occurring and semi-synthetic tetracyclines) and they were designated tetAB(46).
Conclusions: This is the first report of a predicted ABC transporter conferring tetracycline resistance in a
member of the oral microbiota.
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Introduction
Tetracyclines are broad-spectrum antibiotics that are used
extensively to combat bacterial infections in humans and
animals, and have been used as growth promoters in animals,
agriculture and aquaculture.1 – 3 Bacterial resistance to tetracyc-
line is primarily mediated through acquired genes encoding
one of three main mechanisms: active efflux, ribosomal protec-
tion proteins (RPPs), or enzyme-mediated drug inactivation.4
Within the oral cavity, ribosomal protection [e.g. tet(M), tet(Q)
and tet(O)] is the most commonly observed mechanism,
whereas tetracycline-inactivating enzymes and efflux mechan-
isms occur less frequently.5,6
Tetracycline efflux systems have been reported in both
Gram-negative and Gram-positive bacteria.7,8 The best-studied
tetracycline efflux genes [e.g. tet(A) and tet(B)] encode mem-
brane-associated, energy-dependent proteins belonging to the
major facilitator superfamily (MFS) in which proton-motive force
is used to drive efflux.4 However, other tetracycline efflux proteins
not belonging to the MFS group have been reported: (i) Tet(35) of
Vibrio harveyi9 is a member of the H+ antiporter (NhaC) family
and confers resistance to tetracycline, oxytetracycline and
minocycline; and (ii) OtrC of Streptomyces rimosus is predicted
to encode, on distinct polypeptides, the nucleotide-binding
domain (NBD) and membrane-spanning domain (MSD) typical
of members of the ABC transporter family. No functional
information is available for OtrC.4
In this study, we characterize a novel tetracycline resistance
determinant in Streptococcus australis FRStet12, isolated from
pooled saliva from healthy French subjects as part of a study
investigating antibiotic resistance in bacteria colonizing adult
humans.10 We show that two proteins, each encoding predicted
ABC transporter subunits, are both required for tetracycline
resistance.
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Materials and methods
Sample collection and culture
Saliva samples (5 mL) were collected from 20 healthy adult volunteers
who had not received antibiotic therapy in the previous 3 months,
from two centres in France (Faculte´ de Parmacie, Universite´ Paris Sud
and INRA-UEPSD, Domain de Vilvert), as previously described.10 The
samples were pooled in a sterile 200 mL Duran bottle and processed
within 48 h of collection. A 10-fold dilution series was prepared from
1 mL of the sample in Luria–Bertani (LB) broth and spread onto Iso-
Sensitest agar (Oxoid) supplemented with 5% defibrinated horse blood
(E&O Laboratories, Bonnybridge, UK) and 2 mg/L tetracycline. The
plates were incubated in air enriched with 5% CO2 for up to 72 h.
10
Growth at concentrations .2 mg/L is defined as resistant by the BSAC.11
Identification of the resistance genes
Genomic DNA from S. australis FRStet12 was hybridized to a macroarray
containing 23 known tetracycline resistance genes [9 RPP genes—M, O,
B(P), Q, S, T, W, 32 and 36; 12 efflux genes—A, B, C, D, E, G, H, J, A(P),
Y, Z and 30; and 2 enzymatic inactivation genes—tet(X) and tet(34)],
as previously described.12 The genomic DNA was also tested for the pres-
ence of RPP-encoding genes by PCR using a set of universal RPP primers.13
To clone the resistance genes, S. australis FRStet12 genomic DNA was
partially digested with HindIII, ligated into HindIII-digested, depho-
sphorylated pUC19 and transformed into Escherichia coli JM109 compe-
tent cells, according to the supplier’s instructions (Promega). Bacteria
were spread on to LB agar supplemented with 100 mg/L ampicillin and
5 mg/L tetracycline and incubated at 378C in air for up to 36 h. A
tetracycline-resistant clone, designated P9, was isolated and the insert
sequenced.
Species identification
Amplification and sequencing of a manganese-dependent superoxide
dismutase (sodA) gene fragment was carried out according to Poyart
et al.,14 using the primers listed in Table S1 (available as Supplementary
data at JAC Online).
DNA sequencing
To sequence the HindIII genomic DNA fragment of S. australis in pUC19
from clone P9 (pP9), a walking strategy was employed using the
primers listed in Table S1 (available as Supplementary data at JAC
Online).
Mutagenesis
In-frame deletions in tetA(46) and tetB(46) were created using ‘splicing
by overlapping extension’ (SOEing) PCR.15 The hybrid fragments were
ligated into pGEM-T-Easy (Promega) and verified by DNA sequencing.
The DtetA(46) fragment was created using two sets of primer pairs:
ABC1-1F/ABC1-2R and ABC1-3F/ABC1-4R; primers ABC1-2R and
ABC1-3F shared 24 nucleotides of complementary sequence to facilitate
the ligation of the two amplicons (Table S1 available as Supplementary
data at JAC Online). The ligated mutant fragment, when recombined
into the genome, resulted in a 51 bp in-frame deletion (bp 1073–1123
inclusive) in tetA(46). The DtetB(46) fragment was created in the same
way, using two sets of primer pairs: ABC2-1F/ABC2-2R and ABC2-3F/
ABC2-4R; similarly, recombination of this mutagenic fragment resulted
in a 51 bp in-frame deletion (bp 1090–1140 inclusive) in tetB(46). The
DtetA(46) or DtetB(46) mutagenic fragments were co-transformed with
pVA83816 into S. australis FRStet12 to provide selection for successful
transformation (ErmR).
Transformation
Genetic competence was induced in S. australis FRStet12 using a modi-
fied version of the method reported by Hudson and Curtiss.17 A single
colony was inoculated into 10 mL of Todd–Hewitt broth (THB) containing
10% horse serum and incubated at 378C, in air+5% CO2, for 18 h. A 1/40
dilution of the overnight culture was grown in THB plus 10% horse serum
under the same conditions until the optical density at 600 nm was
between 0.1 and 0.2. For co-transformation experiments, 1 mg of either
the DtetA(46) or DtetB(46) mutant fragments plus 250 ng of
pVA83816 were added to 1 mL of culture, mixed and incubated for 3 h
in the CO2-enriched atmosphere. pVA838 is a streptococcal shuttle
plasmid that carries an erythromycin resistance gene as a selectable
marker.16 Aliquots of 100 mL were then spread on to brain heart infusion
(BHI) agar supplemented with 5% defibrinated horse blood plus 10 mg/L
erythromycin and incubated at 378C, in air+5% CO2, for 24 h. Colonies
were then transferred to BHI agar plates supplemented with 5% defibri-
nated horse blood plus 10 mg/L erythromycin and replica plated on to
BHI agar plates supplemented with 5% defibrinated horse blood plus
10 mg/L erythromycin and 5 mg/L tetracycline. All plates were incubated
at 378C, in air+5% CO2, for 24–48 h.
Construction of plasmids for chromosome repair
The wild-type tetA(46) or tetB(46) genes were PCR amplified, ligated into
pVA838 and transformed into the mutant strains, as described above.
The tetA(46) gene was amplified using primers ABC1-8F and ABC1-9R
(Table S1 available as Supplementary data at JAC Online), each contain-
ing XbaI restriction sites. The tetB(46) gene was amplified using primers
ABC2-7F and ABC2-8R, each containing SphI restriction sites (Table S1
available as Supplementary data at JAC Online). The amplified products
were digested with their respective restriction endonucleases and
ligated into either the XbaI or SphI sites of pVA838, creating the recom-
binant plasmids pABC1 and pABC2, respectively. The plasmids were
transformed into E. coli a-select bronze competent cells (Bioline) and
the presence of the wild-type gene confirmed by DNA sequencing. Both
E. coli strains were grown overnight in LB broth supplemented with
80 mg/L chloramphenicol, at 378C, aerobically with shaking at 200 rpm.
Plasmid DNA was extracted using a HiSpeed Plasmid Midi Kit (Qiagen).
Antibiotic susceptibility testing
The MICs of tetracycline, oxytetracycline, doxycycline, chlortetracycline
and tigecycline were determined according to BSAC guidelines.18 The
recommended medium and inoculum (104 cfu/spot) was also used for
determination of the acriflavine and ethidium bromide MICs. Triplicate in-
dividual colonies of each strain were inoculated into 10 mL BHI broth and
incubated at 378C, in air+5% CO2, for 18 h. The cells were diluted and
then spotted, using a multipoint inoculator, on to Iso-Sensitest agar
supplemented with 5% defibrinated horse blood or Iso-Sensitest agar
supplemented with 5% defibrinated horse blood plus the appropriate
antibiotic at concentrations of 0.25–32 mg/L. The plates were incubated
at 378C, in air+5% CO2, for up to 48 h.
Agar diffusion assays were carried out according to BSAC guidelines.11
Discs containing the following amounts of antibiotics were laid on to
agar: tetracycline (10 mg), ciprofloxacin (1 mg), metronidazole (5 mg),
azithromycin (15 mg), ampicillin (2 mg), methicillin (5 mg), oxacillin
(1 mg), penicillin (1 mg) and gentamicin (10 mg). Plates were incubated
at 378C, in air+5% CO2, for 20 h and the zones of inhibition measured.
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Results
S. australis FRStet12 was isolated on agar containing 2 mg/L
tetracycline.19 Sequencing of a sodA gene fragment showed
that the closest relative was the S. australis type strain CIP
107167 (DQ132987), with 95.2% identity. A phylogenetic tree
showing the relationship between the sodA gene fragments of
S. australis FRStet12 and other streptococcal species is shown
in the supplementary data (Figure S1, available as Supplemen-
tary data at JAC Online). To determine whether tetracycline
resistance was conferred by a previously described mechanism,
genomic DNA from S. australis FRStet12 was hybridized to a
macroarray containing known tetracycline resistance genes
and the genomic DNA was also tested for the presence of
RPP-encoding genes by PCR.13 The genomic DNA failed to hybrid-
ize to the macroarray and was negative in the RPP PCR, suggest-
ing the presence of a rare or novel tetracycline resistance
determinant. In our study, of a total of 69 Gram-positive, facul-
tatively anaerobic, tetracycline-resistant isolates, S. australis
FRStet12 was one of only two isolates that failed to hybridize
with the array.19 The other isolate that failed to hybridize has
not been investigated.
To identify the gene(s) conferring resistance in S. australis
FRStet12, a library of HindIII-digested genomic DNA was
created in pUC19, selecting transformants on agar containing
100 mg/L ampicillin and 5 mg/L tetracycline. One tetracycline-
resistant transformant was selected for further study and
designated E. coli P9. The insert from the plasmid in P9 (pP9)
was completely sequenced (accession number HQ652506) and
found to contain five putative open reading frames (orfs), two
of which encoded predicted proteins with similarity to multidrug
resistance (MDR)-type ABC transporters (Figure 1). These genes,
which were both subsequently shown to encode resistance to
tetracycline (see below), have ≤79% amino acid identity to pre-
viously characterized tet genes and were assigned tetA(46) and
tetB(46) under the current naming standards.20 They are pre-
dicted to encode non-identical polypeptides of 574 and 578
amino acids, respectively, each containing an NBD and an MSD
characteristic of the ABC transporter superfamily. TetA(46) and
TetB(46) are most closely related to YheI (36% amino acid iden-
tity) and YheH (35% identity) of Bacillus subtilis, respectively,
which, when overexpressed in E. coli, form a heterodimeric
MDR-type ABC transporter. TetA(46) and TetB(46) show sequence
similarity with other heterodimeric ABC transporters with experi-
mentally proven function, including LmrCD of Lactococcus lactis
and EfrAB of Enterococcus faecalis, as well as related systems
in the Gram-negative bacteria, Serratia marcescens and E. coli
(Table 1).
To determine the function of each gene, 51 bp in-frame
deletions were created within the sequences predicted to
encode the Walker A box of the ATP-binding site of each gene
product using SOEing PCR.15 The mutant gene fragments were
co-transformed26 into S. australis FRStet12 along with plasmid
pVA838,16 making use of the erythromycin resistance gene on
the plasmid for selection. This plasmid was chosen for
co-transformation since our experience showed it to be rapidly
lost from other Streptococcus species in the absence of selection.
Of 90 erythromycin-resistant clones examined following trans-
formation with the tetA(46) mutant fragment and pVA838, five
were unable to grow on 5 mg/L tetracycline and sequence ana-
lysis confirmed the presence of the DtetA(46) allele in all five
(Figure 1). The tetracycline-resistant transformants contained
wild-type tetA(46) and were erythromycin resistant, indicating
they had only taken up pVA838. Despite repeated subculturing
without erythromycin (14 passages in total), pVA838 remained
in the mutant strains. Therefore, to allow comparison between
wild-type and mutant strains, an isogenic strain was created
by transforming the wild-type with pVA838. Of 72 erythromycin-
resistant clones examined following transformation of the
wild-type with the tetB(46) mutant fragment and pVA838, 7
kb
FRStet12
tetA(46)
DtetA(46) mutant 1050 1060 1070 1080 1090 1100 1110 1120 1130 1140
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FRStet12    tetB(46)
FRStet12    DtetB(46)
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tetB(46) orf3 orf4 orf5
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Figure 1. Diagram of the cloned genomic DNA fragment from S. australis FRStet12, indicated by the black line. Five putative orfs are indicated in grey
[tetA(46); tetB(46); orf3, encodes a putative metalloprotease; orf4, encodes a putative diacylglycerol kinase; and orf5, encodes a putative GTP-binding
protein—accession number HQ652506]. The vertical broken black lines indicate the point of the in-frame deletions in tetA(46) and tetB(46) and the
sequence of the deletion is given beneath.
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were unable to grow on 5 mg/L tetracycline and sequencing
confirmed the presence of the DtetB(46) allele (Figure 1), while
those that remained resistant to tetracycline contained wild-type
tetB(46).
To determine whether tetracycline resistance could be
restored in the FRStet12DtetA(46) and FRStet12DtetB(46)
mutants, a chromosome repair was carried out. The wild-type
tetA(46) and tetB(46) genes were cloned into pVA838 to create
the recombinant plasmids pABC1 and pABC2, respectively. In
three independent experiments, transformation of pABC1 into
FRStet12DtetA(46) resulted in colonies on agar containing
5 mg/L tetracycline, whereas transformation with pVA838 alone
did not. Sequence analysis of two tetracycline-resistant transfor-
mants from each of the three independent experiments, using
primers flanking tetA(46) in the chromosome, revealed that in
each case the wild-type tetA(46) had replaced the mutant
allele within the chromosome, demonstrating that wild-type
tetA(46) is required for tetracycline resistance. The transformants
contained empty pVA838 and the mutant DtetA(46) allele was
not detectable by PCR. Transformation of pABC2 into FRStet12D
tetB(46) restored the ability of the mutant strain to grow on
5 mg/L tetracycline, whereas transformation with pVA838 did
not. Sequence analysis of these transformants confirmed that
wild-type tetB(46) had replaced the mutant allele within
the chromosome, demonstrating that wild-type tetB(46) is also
essential for tetracycline resistance.
The MIC of tetracycline was determined for S. australis
FRStet12, S. australis FRStet12 containing pVA838, the
DtetA(46) and DtetB(46) isogenic mutants and their correspond-
ing complemented strains. The MIC for the wild-type and the
complemented strains was 8 mg/L, compared with ,0.25 mg/L
for the DtetA(46) and DtetB(46) mutants. MIC determination of
the other tetracyclines (Table 2) showed that the mutants
were 2- to 8-fold more sensitive to oxytetracycline, doxycycline,
chlortetracycline and tigecycline, indicating that TetAB(46) is also
able to export these molecules. As MDR-type transporters often
are capable of extrusion of other toxic compounds,21,22,24 we
determined the MIC of acriflavine and ethidium bromide but
found no difference between the wild-type and mutant strains.
In addition, we found no difference in the zone size in disc diffu-
sion assays with ciprofloxacin, metronidazole, azithromycin,
ampicillin, methicillin, oxacillin, penicillin or gentamicin, indicat-
ing that TetAB(46) is specific for the transport of tetracyclines.
To determine whether similar genes were present in other
bacteria, BLAST searches were performed. This analysis revealed
orthologues of TetAB(46) in the one draft genome of S. australis
present in the database (NCTC 13166) and in all six of the
Streptococcus parasanguinis draft genomes present in the data-
base (ATCC 903, ATCC 15912, F0405, F0449, FW213 and SK236).
The predicted proteins within these streptococcal genomes share
≥95% amino acid identity with TetA(46) and TetB(46). Since both
S. australis NCTC 13166 and S. parasanguinis NCTC 55898 (ATCC
15912) are resistant to tetracycline (2 mg/L), it is possible that
these tetAB(46) orthologues confer this phenotype.
Discussion
Most tetracycline resistance genes reported in oral bacteria
encode RPPs,6,27,28 whereas efflux genes are rarely detected.
Here, we report the discovery of a predicted tetracycline efflux
determinant, tetAB(46) from S. australis. This species, first iso-
lated from the oral cavities of children in Australia,29 is an oppor-
tunist pathogen reported in sputum samples of adult cystic
fibrosis patients30 and in a case of invasive infection, a
community-acquired meningitis in an elderly patient.31
Most tetracycline efflux proteins belong to the MFS family of
transporters, which are membrane located and exchange a
proton for a tetracycline–cation complex against a concentration
gradient. These have been described in both Gram-positive and
Gram-negative bacteria.7 ABC transporters conferring resistance
to tetracyclines have also been reported. There is one example
currently in the tet nomenclature database: OtrC from
S. rimosus,4 which consists of an NBD and an MSD encoded by
separate genes. While other ABC transporters capable of exporting
tetracycline have been reported, e.g. SmdAB in S. marcescens,22
these are capable of exporting a number of other compounds
Table 1. Comparison between S. australis TetA(46)/TetB(46) and ABC
transporters with experimentally proven function
Organism (reference)
ABC transporter
subunit
Percentage identical
(similar) residues
TetA(46) TetB(46)
S. australis (this study) TetA(46) — 23.3 (52.7)
TetB(46) 23.3 (52.7) —
B. subtilis21 YheI 36.4 (65.3) 26.7 (51.1)
YheH 21.4 (50.1) 34.9 (57.5)
S. marcescens22 SmdA 30.3 (58.6) 25.5 (49.6)
SmdB 23.3 (51.0) 29.1 (54.0)
E. coli23 MdlA 30.3 (57.8) 25.0 (50.2)
MdlB 23.0 (51.6) 28.4 (52.6)
L. lactis24 LmrC 26.2 (55.1) 23.5 (51.5)
LmrD 21.4 (47.2) 26.1 (48.5)
E. faecalis25 EfrA 23.6 (55.0) 25.3 (51.5)
EfrB 25.3 (53.4) 27.7 (56.6)
GenBank proteins numbers: YheI, NP_388852; YheH, NP_388853; SmdA,
BAF79679; SmdB, BAF79680; MdlA, P77265; MdlB, P0AAG5; LmrC, Q9CIP6;
LmrD, Q9CIP5. For the other sequences, Swiss-Prot entries (in parentheses)
were used: EfrA (Q82ZX7_ENTFA); and EfrB (Q82ZX8_ENTFA). Percentage
identity and similarity were obtained by sequence alignment using Clustal W
at http://npsa-pbil.ibcp.fr/.
Table 2. MICs of tetracyclines for S. australis FRStet12 and the tetAB(46)
mutant strains
Strain Oxytetracycline Doxycycline Chlortetracycline Tigecycline
FRStet12 8 0.5 4 1
FRStet12
DABC1
1 ,0.25 0.5 ,0.25
FRStet12
DABC2
2 ,0.25 0.5 ,0.25
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and have not therefore been given a tetracycline resistance
gene designation.
Analysis of S. australis FRStet12 revealed two orfs responsible
for tetracycline resistance, which are most closely related to YheI
and YheH of B. subtilis. YheI and YheH are non-identical ABC trans-
porter subunits, each containing an NBD and an MSD, which were
shown to interact to form a heterodimeric multidrug ABC trans-
porter capable of transporting several structurally dissimilar
drugs, such as fluorescently labelled ethidium bromide and dau-
nomycin.21 Another related MDR transporter is LmrCD of L. lactis,
also shown to be capable of extrusion of a range of structurally
unrelated drugs.24 Expression of E. faecalis EfrA and EfrB together
in E. coli confers resistance to a range of drugs, including acrifla-
vine, norfloxacin and doxycycline. Further, energy-dependent
efflux of acriflavine in E. coli harbouring efrAB was also demon-
strated.25 MDR-type ABC transporters from S. marcescens and
E. coli are also related to TetAB(46): although there are no func-
tional data for the E. coli system,23 SmdAB of S. marcescens has
been shown to confer multidrug, including tetracycline, resistance
on E. coli and to be inhibited by ATPase inhibitors.22
Of the tetracycline (tet) and oxytetracycline (otr) resistance
genes currently listed in the tetracycline gene nomenclature
database (http://faculty.washington.edu/marilynr/), 28 code for
active efflux, 12 for ribosomal protection, 3 for enzymatic drug
inactivation and 1 has an unknown mechanism. The two genes
required for tetracycline resistance in S. australis FRStet12 were
designated tetA(46) and tetB(46) under the current naming
standards.20
In-frame deletions in either tetA(46) or tetB(46) demon-
strated that both were required for tetracycline resistance in
S. australis. The fact that the genes encode non-identical pro-
teins, each containing a predicted MSD and NBD, suggests that
they may function as a heterodimeric ABC transporter, although
confirmation of this requires demonstration of a physical inter-
action between the two proteins, experiments that are beyond
the scope of the present study.
During the course of this work, we made two observations on
the molecular biology of S. australis that are worthy of discussion.
Firstly, we report the maintenance of pVA838 after multiple pas-
sages in the absence of selection, which is unusual in our experi-
ence with this plasmid in other streptococci. The stability of
‘empty’ pVA838 in the mutant strains may have contributed to
the second unexpected result obtained in this work: in ex-
periments designed to introduce the wild-type alleles in trans,
transformation of both mutants with the wild-type alleles
cloned in pVA838 resulted in chromosome repair, i.e. double
crossover recombination occurred, resulting in replacement of
the mutant allele with the wild-type allele in the chromosome,
and this restored the tetracycline resistance phenotype.
However, instead of detecting the mutant allele in the plasmid
as expected following double crossover, we detected only
pVA838 without an insert in these strains and did not detect
the presence of the mutant alleles. This result was reproduced
in triplicate for both mutants. One explanation is that following
allelic exchange, the plasmid carrying the mutant allele was
lost from the population because of the fitness disadvantage
associated with its replication, compared with replication of the
plasmid without the insert.
Despite homology to proven multidrug transporters, TetA(46)
and TetB(46) were found to confer resistance only to tetracyclines.
The MFS efflux systems transport only the naturally occurring tet-
racyclines, with the exception of TetA(B), which also transports
the semi-synthetic analogue, minocycline.7 The reduced MICs
in the tetA(46) and tetB(46) mutants indicate that TetAB(46) is
able to transport both tetracycline and its semi-synthetic deriva-
tives. We have previously shown that S. australis FRStet12 is sen-
sitive to minocycline (MIC of 0.25 mg/L).32 Since MDR-type ABC
transporters have been shown to extrude toxic molecules other
than antibiotics,24,25 we determined the MICs of acriflavine and
ethidium bromide, but found no difference between the wild-
type and mutant strains. Thus, our data suggest that TetAB(46)
is specific for tetracyclines.
In conclusion, we have identified a novel tetracycline resist-
ance determinant, tetAB(46), in an oral viridans Streptococcus
species. TetAB(46) is related to known MDR-type ABC transpor-
ters in both Gram-positive and Gram-negative bacteria, but
confers resistance only to tetracyclines. Genes highly related
to tetAB(46) are present in the genomes of other tetracycline-
resistant oral streptococci, including several strains of S. parasan-
guinis and another strain of S. australis.
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